Literature DB >> 19446797

Major depression is a risk factor for low bone mineral density: a meta-analysis.

Raz Yirmiya1, Itai Bab.   

Abstract

BACKGROUND: The role of depression as a risk factor for low bone mineral density (BMD) and osteoporosis is not fully acknowledged, mainly because the relevant literature is inconsistent and because information on the mechanisms mediating brain-to-bone signals is rather scanty.
METHODS: Searching databases and reviewing citations in relevant articles, we identified 23 studies that quantitatively address the relationship between depression and skeletal status, comparing 2327 depressed with 21,141 nondepressed individuals. We subjected these studies to meta-analysis, assessing the association between depression and BMD as well as between depression and bone turnover markers.
RESULTS: Overall, depressed individuals displayed lower BMD than nondepressed subjects, with a composite weighted mean effect size (d) of -.23 (95% confidence interval: -.33 to -.13; p < .001). The association between depression and BMD was similar in the spine, hip, and forearm. It was stronger in women (d = -.24) than men (d = -.12) and in premenopausal (d = -.31) than postmenopausal (d = -.12) women. Only women individually diagnosed for major depression by a psychiatrist with DSM criteria displayed significantly low BMD (d = -.36); women diagnosed by self-rating questionnaires did not (d = -.06). Depressed subjects had increased urinary levels of bone resorption markers (d = .52).
CONCLUSIONS: The present findings portray depression as a significant risk factor for low BMD. Premenopausal women who are psychiatrically diagnosed with major depression are particularly at high-risk for depression-associated low BMD. Hence, periodic BMD measurements and antiosteoporotic prophylactic and curative measures are strongly advocated for these patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19446797     DOI: 10.1016/j.biopsych.2009.03.016

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  39 in total

Review 1.  Depression and osteoporosis: a research synthesis with meta-analysis.

Authors:  G Cizza; S Primma; M Coyle; L Gourgiotis; G Csako
Journal:  Horm Metab Res       Date:  2010-05-07       Impact factor: 2.936

Review 2.  Evolving concepts in neurogenic osteoporosis.

Authors:  Weiping Qin; William A Bauman; Christopher P Cardozo
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

3.  Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.

Authors:  Christoph U Correll; Johan Detraux; Jan De Lepeleire; Marc De Hert
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

Review 4.  A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis.

Authors:  S Lekamwasam; J D Adachi; D Agnusdei; J Bilezikian; S Boonen; F Borgström; C Cooper; A Diez Perez; R Eastell; L C Hofbauer; J A Kanis; B L Langdahl; O Lesnyak; R Lorenc; E McCloskey; O D Messina; N Napoli; B Obermayer-Pietsch; S H Ralston; P N Sambrook; S Silverman; M Sosa; J Stepan; G Suppan; D A Wahl; J E Compston
Journal:  Osteoporos Int       Date:  2012-03-21       Impact factor: 4.507

5.  Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics.

Authors:  Chadi A Calarge; Vicki L Ellingrod; Bridget Zimmerman; Michael M Bliziotes; Janet A Schlechte
Journal:  J Clin Psychiatry       Date:  2011-12       Impact factor: 4.384

6.  Dysregulation of vitamin D metabolism in the brain and myocardium of rats following prolonged exposure to dexamethasone.

Authors:  Pei Jiang; Ying Xue; Huan-De Li; Yi-Ping Liu; Hua-Lin Cai; Mi-Mi Tang; Li-Hong Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-01-22       Impact factor: 4.530

Review 7.  Impact of the Autonomic Nervous System on the Skeleton.

Authors:  Florent Elefteriou
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

8.  The Effect of Depression, Generalized Anxiety, and Selective Serotonin Reuptake Inhibitors on Change in Bone Metabolism in Adolescents and Emerging Adults.

Authors:  Chadi A Calarge; James A Mills; Kathleen F Janz; Trudy L Burns; Janet A Schlechte; William H Coryell; Babette S Zemel
Journal:  J Bone Miner Res       Date:  2017-09-22       Impact factor: 6.741

9.  Longitudinal impact of substance use and depressive symptoms on bone accrual among girls aged 11-19 years.

Authors:  Lorah D Dorn; Sarah J Beal; Heidi J Kalkwarf; Stephanie Pabst; Jennie G Noll; Elizabeth J Susman
Journal:  J Adolesc Health       Date:  2012-12-03       Impact factor: 5.012

Review 10.  Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures?

Authors:  Stuart J Warden; Robyn K Fuchs
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.